CHOICE OF ANTITHROMBOTIC DRUG IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD PRACTICE

被引：0
|
作者：
Citarella, A. [1 ]
Cammarota, S. [1 ]
Creazzola, S. [2 ]
De Marino, C. [2 ]
Izzo, P. [2 ]
La Bella, G. [2 ]
Piscitelli, R. [2 ]
Romagnuolo, F. [2 ]
Esposito, E. [2 ]
Guida, A. [2 ]
机构：
[1] LinkHealth Srl, Naples, Italy
[2] Local Hlth Author, Naples, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.806
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV38
引用
收藏
页码：A380 / A380
页数：1
相关论文
共 50 条
  • [31] Peripheral leukocyte count and risk of bleeding in patients with non-valvular atrial fibrillation taking dabigatran: a real-world study
    Zhou Wei
    Wang Tao
    Zhu Ling-Juan
    Wen Ming-Hua
    Hu Li-Hua
    Huang Xiao
    You Chun-Jiao
    Li Ju-Xiang
    Wu Yan-Qing
    Wu Qing-Hua
    Bao Hui-Hui
    Cheng Xiao-Shu
    中华医学杂志英文版, 2019, 132 (18) : 2150 - 2156
  • [32] Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice
    Boulanger, L
    Kim, J
    Friedman, M
    Hauch, O
    Foster, T
    Menzin, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (03) : 258 - 264
  • [33] Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
    Pugh, Andrew
    Campbell, Charlotte
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] The appropriateness of antithrombotic therapy after stroke or TIA in patients with non-valvular atrial fibrillation
    Fawcett, C
    Appadurai, K
    Kratzing, L
    Read, S
    Yelland, C
    STROKE, 2000, 31 (11) : 2868 - 2869
  • [35] Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
    Berger, Jeffrey S.
    Laliberte, Francois
    Kharat, Akshay
    Lejeune, Dominique
    Moore, Kenneth Todd
    Jung, Young
    Lefebvre, Patrick
    Ashton, Veronica
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (06) : 881 - 890
  • [36] Real-world Oral anticoagulants for Asian patients with Non-valvular Atrial Fibrillation : A Systematic Review and Network Meta-analysis
    Kim, Seung Min
    Jeon, Eun-tae
    Kim, Seong Hwan
    Lee, Ji-sung
    Jung, Jin-man
    CEREBROVASCULAR DISEASES, 2020, 49 (SUPPL 1) : 123 - 123
  • [37] A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
    Alosaimi, Hind M.
    Alqahtani, Saeed
    Balkhi, Bander
    Alqahtani, Mishari
    Alzamil, Faisal
    Alhossan, Abdulaziz
    Alqahtany, Fatmah S.
    Alharbi, Abdullah A.
    Alqahtani, Nawaf Abdullah
    Albackr, Hanan
    Elgohary, Ghada
    Algahtani, Farjah H.
    PEERJ, 2022, 10
  • [38] Real-world evidence of stroke prevention in patients with non-valvular atrial fibrillation in the United States: the REVISIT-US study
    Coleman, C.
    Antz, M.
    Simard, E.
    Evers, T.
    Bowrin, K.
    Bonnemeier, H.
    Cappato, R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 504 - 504
  • [39] Patient profile in non-valvular atrial fibrillation (NVAF) and stroke: findings from a real-world setting in Spain
    Lefevre, C.
    Benhaddi, H.
    Lacoin, L.
    Cuervo, H. Diaz
    Lee, Y. -C.
    Evans, D.
    Budd, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 906 - 906
  • [40] Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study
    Faggiano, Pompilio
    Dinatolo, Elisabetta
    Moreo, Antonella
    De Chiara, Benedetta
    Sbolli, Marco
    Musca, Francesco
    Curnis, Antonio
    Belli, Oriana
    Giannattasio, Cristina
    Tomasi, Cesare
    Metra, Marco
    Santangelo, Gloria
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
12345